Search

To link to full-text access for this article, visit this link: http://dx.doi.org/10.1016/j.ahj.2005.02.045 Byline: Edmundo Arteaga, Aloir Queiroz Araujo, Paula Buck, Barbara Maria Ianni, Rogerio Rabello, Charles Mady Abstract: Plasma B-type natriuretic peptide (BNP) is a sensitive functional marker in heart disease including hypertrophic cardiomyopathy (HCM). The utility of plasma amino-terminal pro-BNP (NT-proBNP) quantification in heart disease has been investigated, but there are no published data regarding this test in HCM. Author Affiliation: Heart Institute (InCor), University of Sao Paulo Medical School, Sao Paulo, Brazil Article History: Received 13 May 2004; Accepted 20 February 2005

To link to full-text access for this article, visit this link: http://dx.doi.org/10.1016/j.ahj.2004.08.021 Byline: Afonso Y. Matsumoto (a)(b), Edmundo Arteaga (a), Barbara M. Ianni (a), Ana M.F.W. Braga (a), Paula C. Buck (a), Charles Mady (a) Abstract: The aim of this study was to analyze the relationships among exercise capacity (EC), hypertrophy, and diastolic function in nonobstructive hypertrophic cardiomyopathy (NOHCM). Author Affiliation: (a) Departmnet of Cardiomyopathy, Heart Institute (InCor), University of Sao Paulo Medical School, Sao Paulo, Brazil (b) Laboratorio Fleury, Sao Paulo, Brazil Article History: Received 29 January 2004; Accepted 22 August 2004

To link to full-text access for this article, visit this link: http://dx.doi.org/10.1016/j.ahj.2004.09.049 Byline: Edmundo Arteaga, Barbara Maria Ianni, Fabio Fernandes, Charles Mady Abstract: Selected patients with hypertrophic cardiomyopathy (HCM) have 3% to 4% annual mortality as compared to only 0.5% to 1.5% in nonselected patients. Our aim was to evaluate survival and prognostic factors in HCM in patients in a tertiary care center. Author Affiliation: Cardiomyopathy Division, University of Sao Paulo Medical School, Heart Institute (InCor), Sao Paulo, Brazil Article History: Received 13 May 2004; Accepted 20 September 2004